VIable
HLCCompendium
HLCCompendium
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
NDHI<br />
NAT IONAL DIALOGUE FOR<br />
Healthcare Innovation<br />
Healthcare Innovation That<br />
Supports Clinical Process<br />
Improvement<br />
Organization Overview<br />
C. R. Bard, Inc. (BARD) is a multinational developer,<br />
manufacturer and marketer of innovative medical<br />
devices focused primarily in the areas of Vascular,<br />
Urology, Oncology and Surgical Specialties. BARD is<br />
dedicated to pursuing technological innovations that<br />
offer superior clinical benefits while helping to reduce<br />
overall healthcare costs.<br />
BARD holds itself to the highest ethical standards to<br />
assign measurable, robust, clinical and economic<br />
value to healthcare and to deliver safe and effective<br />
products and programs.<br />
Background<br />
As ‘Value’ has become paramount to healthcare providers<br />
in this era of accountable care delivery, healthcare<br />
providers are faced with increasing operational costs<br />
while patients are presenting with more risk factors.<br />
The balance of cost and outcomes involves addressing<br />
key challenges in controlling procedural complications<br />
such as infection, radiation exposure, and variation in<br />
treatment protocols, often in addition to sub-optimal<br />
product use or selection. There needs to be a focus<br />
on using the right product for the right patient at the<br />
right cost.<br />
Product Details<br />
Even though hospitals educate on proper techniques,<br />
clinical management practices often vary, potentially<br />
resulting in less than optimal outcomes. Product selection<br />
standardization, a key component of procedural<br />
standardization, can help clinicians as they seek to<br />
achieve optimal product performance, use and outcomes.<br />
BARD is helping reinforce the importance of procedural<br />
standardization in many ways. One example<br />
is through the introduction of the BARD SURESTEP<br />
Foley Catheter Tray. This is an integrated system<br />
of product labeling that guides the clinician through<br />
product selection and use, which encompasses foley<br />
catheter insertion as well as the care and maintenance<br />
of these devices.<br />
BARD has also developed products that offer unique<br />
clinical advantages coupled with process improvement<br />
programs. Take, for example, the GEOALIGN ®<br />
Marking system, which can be used as an alignment<br />
tool during repeat catheterization procedures. The<br />
GEOALIGN ® Marking system is designed to accurately<br />
align the device at the target lesions, thus helping with<br />
procedural efficiency to reduce fluoroscopy time and<br />
any associated radiation exposure to both patients<br />
and clinicians.<br />
An Initiative of the<br />
51 |<br />
Healthcare Innovation That Supports Clinical Process Improvement